Etomidate Injection
Product Images NDC 0143-9311

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 0143-9311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etomidate Injection Usp Novaplus 1)

Chemical structure of Etomidate, depicting its molecular arrangement including the imidazole ring and associated functional groups.*

FDA Label Image

Logo2 (Etomidate Injection Usp Novaplus 2)

FDA Label Image

Plb155 (Etomidate Injection Usp Novaplus 3)

Etomidate Injection, USP 20 mg per 10 mL (2 mg/mL) intravenous injection vial label from Hikma Pharmaceuticals USA Inc. The label indicates it is for single-dose use, sterile, nonpyrogenic, with storage instructions between 20 to 25°C. The label also shows barcodes and cautions that it is for prescription use only.*

FDA Label Image

Plb156.2 (Etomidate Injection Usp Novaplus 4)

Label for Etomidate Injection, USP 20 mg per 10 mL (2 mg/mL) by Hikma Pharmaceuticals USA Inc. The label indicates it is for intravenous use and comes in 10 single-dose 10 mL vials. It includes storage instructions and mentions the solution contains 2 mg/mL etomidate with 35% propylene glycol, sterile and nonpyrogenic.*

FDA Label Image

Plb157 (Etomidate Injection Usp Novaplus 5)

Etomidate Injection USP 40 mg per 20 mL (2 mg/mL) single-dose vial label for intravenous use. The label includes storage instructions (20 to 25°C), dosage reference to package insert, and manufacturer details: Hikma Pharmaceuticals USA Inc. The label indicates the product is sterile, nonpyrogenic, and contains propylene glycol as a solvent.*

FDA Label Image

Plb158 (Etomidate Injection Usp Novaplus 6)

Etomidate Injection, USP 40 mg per 20 mL (2 mg/mL) for intravenous use. Packaging label indicates 10 x 20 mL single dose vials. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc, Berkeley Heights, NJ. The label includes storage instructions and formulation details such as propylene glycol 35% v/v.*

FDA Label Image

Etomidate Injection Usp Novaplus 7

Packaging label for Etomidate injection, 2 mg/mL, by Hikma Pharmaceuticals USA Inc. The label includes a QR code along with printed identifiers such as GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label is designed for an intravenous injection product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.